A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer

✍ Scribed by Helmut Friess; Jan M Langrehr; Helmut Oettle; Jochen Raedle; Marco Niedergethmann; Christian Dittrich; Dieter K Hossfeld; Herbert Stöger; Bart Neyns; Peter Herzog; Pascal Piedbois; Frank Dobrowolski; Werner Scheithauer; Robert Hawkins; Frieder Katz; Peter Balcke; Jan Vermorken; Simon van Belle; Neville Davidson; Albert Abad Esteve; Daniel Castellano; Jörg Kleeff; Adrien A Tempia-Caliera; Andreas Kovar; Johannes Nippgen

• Book ID: 115010913
• Publisher: BioMed Central
• Year: 2006
• Tongue: English
• Weight: 388 KB
• Volume: 6
• Category: Article
• ISSN: 1471-2407
• DOI: 10.1186/1471-2407-6-285